CITED2 antibody - N-terminal region (ARP35789_P050)

Product Specifications

CAS Number

9007-83-4

Gene Name

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

Gene Aliases

ASD8, MRG1, VSD2, MRG-1, P35SRJ

Gene ID

10370

Swiss Prot

Q99967

Accession Number

NP_006070

Reactivity

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Sheep

Immunogen

The immunogen is a synthetic peptide directed towards the N terminal region of human CITED2

Target

CITED2 belongs to the CITED family. It interferes with the binding of transcription factors HIF-1a and STAT2 to p300/CBP.

Partner Proteins

UBC; ELAVL1; EP300; SMAD3; SMAD2; LHX2; HIF1A; TFAP2C; LHX3; CREBBP; TFAP2A; TBP; TFAP2B

Clonality

Polyclonal

Type

Polyclonal Antibody

Sequence

HIHYGAGNMNATSGIRHAMGPGTVNGGHPPSALAPAARFNNSQFMGPPVA

Applications

WB, IHC

Purification

Affinity Purified

Assay Protocol

Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol